CXCL8/IL-8 Rekombinanter Antikörper
CXCL8/IL-8 Rekombinant Antikörper für FC (Intra)
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
FC (Intra)
Konjugation
Unkonjugiert
CloneNo.
240889B2
Kat-Nr. : 98137-1-RR
Synonyme
Geprüfte Anwendungen
Erfolgreiche Detektion in FC (Intra) | IFN gamma, LPS and Brefeldin A treated human PBMCs |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Produktinformation
98137-1-RR bindet in FC (Intra) CXCL8/IL-8 und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | Rekombinantes Protein |
Vollständiger Name | interleukin 8 |
Berechnetes Molekulargewicht | 99 aa, 11 kDa |
GenBank-Zugangsnummer | BC013615 |
Gene symbol | IL-8 |
Gene ID (NCBI) | 3576 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein A purfication |
Lagerungspuffer | PBS with 0.09% sodium azide |
Lagerungsbedingungen | Store at 2 - 8°C. Stable for one year after shipment. |
Hintergrundinformationen
Interleukin 8 (IL-8), also known as CXCL8, is a CXC chemokine family member. This chemokine is secreted by a variety of cell types including monocyte/macrophages, T cells, neutrophils, fibroblasts, endothelial cells, and various tumor cell lines in response to inflammatory stimuli. IL-8 has two primary functions. It induces chemotaxis in target cells, primarily neutrophils but also other granulocytes, causing them to migrate toward the site of infection. IL-8 also induces phagocytosis once they have arrived. This gene is believed to play a role in the pathogenesis of bronchiolitis, a common respiratory tract disease caused by viral infection. IL-8 is also known to be a potent promoter of angiogenesis. IL-8 has been associated with tumor angiogenesis, metastasis, and poor prognosis in breast cancer. IL-8 may present a novel therapeutic target for estrogen driven breast carcinogenesis and tumor progression.
Protokolle
PRODUKTSPEZIFISCHE PROTOKOLLE | |
---|---|
FC protocol for CXCL8/IL-8 antibody 98137-1-RR | Download protocol |
STANDARD-PROTOKOLLE | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |